CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 167 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$10,254,000
+36.8%
110,327
-12.4%
0.01%
+16.7%
Q3 2021$7,497,000
-20.6%
125,900
-9.0%
0.01%
-14.3%
Q2 2021$9,437,000
-4.2%
138,375
-2.5%
0.01%0.0%
Q1 2021$9,849,000
-12.2%
141,934
-2.8%
0.01%
-22.2%
Q4 2020$11,214,000
+13.1%
145,962
+10.1%
0.01%0.0%
Q3 2020$9,916,000
+26.0%
132,583
+6.0%
0.01%
+12.5%
Q2 2020$7,872,000
+63.4%
125,048
+9.0%
0.01%
+33.3%
Q1 2020$4,817,000
-31.8%
114,695
-26.2%
0.01%0.0%
Q4 2019$7,059,000
+40.4%
155,425
+41.5%
0.01%
+20.0%
Q3 2019$5,029,000
+34.3%
109,868
+72.0%
0.01%
+25.0%
Q2 2019$3,745,000
+35.0%
63,870
+3.2%
0.00%
+33.3%
Q1 2019$2,775,000
+13.6%
61,893
-1.3%
0.00%0.0%
Q4 2018$2,442,000
-22.0%
62,693
-7.8%
0.00%
-25.0%
Q3 2018$3,129,000
+0.6%
67,993
-4.7%
0.00%0.0%
Q2 2018$3,111,000
+35.9%
71,346
+23.1%
0.00%
+33.3%
Q1 2018$2,290,000
+31.2%
57,972
+12.8%
0.00%
+50.0%
Q4 2017$1,746,000
+37.8%
51,400
+3.4%
0.00%0.0%
Q3 2017$1,267,000
+51.2%
49,7000.0%0.00%
+100.0%
Q2 2017$838,00049,7000.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Prosight Management, LP 139,528$6,083,0004.46%
Eversept Partners, LP 134,151$5,848,9842.68%
DAFNA Capital Management LLC 95,242$4,153,0001.94%
GREAT POINT PARTNERS LLC 302,000$13,167,0001.82%
Atika Capital Management LLC 190,000$8,284,0001.59%
Crawford Lake Capital Management, LLC 205,600$8,964,0001.57%
Crawford Lake Capital Management, LLC 205,688$8,968,0001.57%
Cormorant Asset Management, LP 450,000$19,620,0001.45%
SENZAR ASSET MANAGEMENT, LLC 11,123$485,0001.40%
Rhenman & Partners Asset Management AB 284,621$12,409,0001.27%
View complete list of ARENA PHARMACEUTICALS INC shareholders